The Healthix Vendor Interoperability Program (VIP) supports vendors seeking to simplify interoperability with healthcare providers. As part of our VIP program, organizations have access to all Healthix technical specifications and industry-leading interoperability models to help support product development and expansion, thereby eliminating the expense and need to build and maintain costly aggregation platforms. To Learn More about the VIP Program, Click Here>
The Staten Island PPS has created a Social Determinant of Health (SDOH) App called WeSource. Currently, Community Based Organizations, hospitals, FQHCs, behavioral health and primary care practices use the WeSource app to identify and meet client SDOH needs. The App may be used to screen any population, it is payer agnostic and may also be used for uninsured individuals. Trusted referral sources vetted and approved by the organizations using the tool are loaded into a referral data base. The App facilitates follow-up to close the loop of electronic referrals made to different social services, and feeds responses to the client’s electronic health record or care coordination platform. This referral roster is easily updated to provide the most current resources and scope for the organizations making referrals. By partnering with Healthix the SDOH data exchange combined with health records creates a 360 view of the client like never before and reduces workload and redundancy for collaborating agencies working to meet client needs. Insurance plans and public agencies may use WeSource to complete an annual or recurring survey of their clients. This can be accomplished by sending a live link via email, text or hosting the link live on their website or patient portal for easy access. In order to provide agency to an individual the 2.0 version will offer a patient activated option so clients can make their evolving needs known and request navigation support before crisis level issues develop.
mProbe Inc. is a biotechnology company founded out of Stanford University, promoting human health and wellness by transforming the fields of Precision Medicine, Precision Health, and Precision Healthcare Analytics. We use a proprietary combination of artificial intelligence and multi-omic diagnostics, to advance how disease is predicted, prevented and treated.
In precision health, we identify phenotype patterns to recognize and interpret biological pathway irregularities that predict health risks and detect early disease onset or progression to prevent or address chronic diseases and their complications or inform interventions.
In precision medicine, we help oncologists choose the most effective therapies based on the individual’s tumor biology.
In precision analytics, we provide predictive risk solutions to hospitals and health systems, ACOs, CINs, HIEs and health plans. Our solutions provide real-time surveillance in an acute or emergency episode to predict intra-episode events and inform admission, discharge and follow-up decisions, while our population and transition risk solutions help customers stratify populations to mitigate risk of adverse events, costs and chronic conditions, helping clients succeed in value-based care.